Trial Profile
A study investigating the effect of sofosbuvir-based therapy in liver transplant recipients who were suffering from recurrent hepatitis C and HIV infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin; Simeprevir; Tacrolimus
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms NU-VHR
- 11 Jan 2016 New trial record
- 02 Jan 2016 Results published in the AIDS